ReviewWorld journal of clinical pediatrics2016
Retinopathy of prematurity: Past, present and future.
Review in World journal of clinical pediatrics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
82 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Costs associated with retinopathy of prematurity: a systematic review and meta-analysis.BMJ open · 2022Pooled it
- Neurodevelopmental Disorders in Infants Treated with Anti-VEGF Agents versus Laser Photocoagulation or Cryotherapy for Retinopathy of Prematurity.Ophthalmology science · 2026Article
- Unit-based evaluation of retinopathy of prematurity screening practices in Turkiye within the framework of current guidelines.International ophthalmology · 2026Article
- Semi-automated quantification of total and avascular retinal area in the rat model of oxygen-induced retinopathy.Angiogenesis · 2026Article
- Evaluation of regression, reactivation, retreatment and retinal detachment after injections of three different anti-VEGF drugs for retinopathy of prematurity.Scientific reports · 2026Article
- Machine learning-based individualized prediction: risk assessment of retinopathy in preterm infants at high altitude.BMC ophthalmology · 2026Article
- Leveraging deep learning to infer continuous predictions from ordinal labels in medical imaging.PLOS digital health · 2026Article
- Maternal Determinants of Retinopathy of Prematurity (ROP): Spotlight on Gestational Diabetes Mellitus.Cureus · 2026Article
- Review
- Ocular surface inflammatory cytokines as a biomarker for retinopathy of prematurity.Eye (London, England) · 2026Article
- Assessing the Prevalence and Determinants of Retinopathy of Prematurity in King Saud Medical City, Saudi Arabia.Cureus · 2026Article
- Efavirenz treatment improves retinal vaso-obliteration and pathological neovascularization in a mouse model of retinopathy of prematurity.Frontiers in medicine · 2026Article
- Severe ROP rate and assessment of the burden of ROP screening at a single tertiary care public hospital in Pakistan.BMC ophthalmology · 2025Article
- Prevalence and associated factors for retinopathy of prematurity at a tertiary hospital in Dar es Salaam, Tanzania.Eye (London, England) · 2025Article
- Incidence and risk factors of retinopathy of prematurity in Palestine: a retrospective cohort study, 2024.BMC ophthalmology · 2025Article
- AI-Enabled Screening for Retinopathy of Prematurity in Low-Resource Settings.JAMA network open · 2025Article
- The use of neural networks to determine factors affecting the severity and extent of retinopathy in preterm infants.International journal of retina and vitreous · 2025Article
- The Role of Acute Phase Reactants, Including α1-Acid Glycoprotein, in Predicting Onset and Severity of Retinopathy of Prematurity.Diagnostics (Basel, Switzerland) · 2025Article
- Article
- Polystyrene microplastics impair the function of human retinal microvascular endothelial cells and pericytes and increase vascular permeabilityFrontiers in medicine · 2025Article
22 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the retina occurring principally in new born preterm infants. It is an avoidable cause of childhood blindness. With the increase in the survival of preterm babies, ROP has become the leading cause of preventable childhood blindness throughout the world. A simple screening test done within a few weeks after birth by an ophthalmologist can avoid this preventable blindness. Although screening guidelines and protocols are strictly followed in the developed nations, it lacks in developing economies like India and China, which have the highest number of preterm deliveries in the world. The burden of this blindness in these countries is set to increase tremendously in the future, if corrective steps are not taken immediately. ROP first emerged in 1940s and 1950s, when it was called retrolental fibroplasia. Several epidemics of this disease were and are still occurring in different regions of the world and since then a lot of research has been done on this disease. However, till date very few comprehensive review articles covering all the aspects of ROP are published. This review highlights the past, present and future strategies in managing this disease. It would help the pediatricians to update their current knowledge on ROP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.